Log in to save to my catalogue

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-...

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2272250172

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B

About this item

Full title

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-08, Vol.14 (8), p.e0220903-e0220903

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth factor-β (TGF-β) properties, can protect muscles in various types of MD such as Duchenne MD, suggesting a...

Alternative Titles

Full title

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2272250172

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2272250172

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0220903

How to access this item